Get startedLog in
    Picture of Suzhou Ribo Life Science logo

    6938 — Suzhou Ribo Life Science News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapSucker Stock
    All News

    Brief: Suzhou Ribo Life Science Says Phase III Clinical Trial Of RBD7022 Injection To Start In China

    Picture of Suzhou Ribo Life Science logoSuzhou Ribo Life Science
    02/03/2026 01:43
    March 2 (Reuters) - Suzhou Ribo Life Science Co Ltd 6938.HK:

PHASE III CLINICAL TRIAL OF RBD7022 INJECTION FOR TREATMENT OF HYPERLIPIDEMIA TO BE INITIATED IN CHINA

Further company coverage: 6938.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Suzhou Ribo Life Science

    See all news